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ABSTRACT
Objective: The aim of this study was to study and assess the indications of acid suppressive drugs and 
to find out percentage of irrational prescriptions with acid suppressive drugs.
Material/Methods: It is a prospective observational study conducted in the Armed Forces Hospitals 
Southern Region and Abha Maternity Hospital, both in Abha in Assir region (Saudi Arabia). The sample 
size of study was 185 patients. The case sheets of the patients’ prescription order were reviewed for acid 
suppressive drugs prescription and relevant data was taken. Patients’ age above 18 were identified. The 
duration of study was 8 weeks, between May and June 2017.
Results: Our results showed that the majority of the prescriptions of proton pump inhibitors (68.1%) 
were unjustifiable and that proton pump inhibitor was the most commonly prescribed acid suppressive 
drugs for the patients (97.8%). The frequency of prescribing for the autism spectrum disorders in our 
study was found to be higher in patients with an existing risk factor and was mostly recommended by 
physicians as concomitant medications (67.6%). The most common concomitant medications used with 
the proton pump inhibitors were non-steroidal anti-inflammatory drugs (29.2%) in which aspirin com-
posed 13.5% of the non-steroidal anti-inflammatory drugs prescribed followed by antimicrobials (9.2%).
Conclusion: Acid suppressive drugs are the most commonly prescribed drugs with no proper indica-
tions hence irrational. Based on the results of this study, creating awareness about reasonable use of acid 
suppressive drugs is a necessity.
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RESUMEN
Objetivo: El objetivo de este estudio fue estudiar y evaluar las indicaciones de los medicamentos supre-
sores de ácidos y averiguar el porcentaje de recetas irracionales con medicamentos supresores de ácidos.
Material / Métodos: es un estudio observacional prospectivo realizado en los Hospitales de las Fuerzas 
Armadas del Sur y en el Hospital de Maternidad Abha, ambos en Abha en la región de Assir (Arabia 
Saudita). El tamaño muestral del estudio fue de 185 pacientes. Se revisaron las hojas de casos de orden 
de prescripción de los pacientes para la prescripción de medicamentos supresores de ácido y se tomaron 
los datos pertinentes. Se identificó la edad de los pacientes mayores de 18 años. La duración del estudio 
fue de 8 semanas, entre mayo y junio de 2017.
Resultados: nuestros resultados mostraron que la mayoría de las prescripciones de inhibidores de la 
bomba de protones (68,1%) eran injustificables y que este era el fármaco supresor de ácido más común-
mente prescrito para los pacientes (97,8%). La frecuencia de prescripción para los trastornos del espectro 
autistas en nuestro estudio, fue mayor en pacientes con un factor de riesgo existente y fue recomendada 
principalmente por los médicos como medicamentos concomitantes (67,6%). Los medicamentos con-
comitantes más comunes que se usaron con los inhibidores de la bomba de protones fueron los antiin-
flamatorios no esteroideos (29.2%) en los cuales la aspirina supuso el 13,5% de los antiinflamatorios no 
esteroideos prescritos, seguidos por los antimicrobianos (9.2%)
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Conclusión: los medicamentos supresores de ácido son los medi-
camentos más comúnmente recetados sin indicaciones adecuadas, 
por lo que son irracionales. Basado en los resultados de este estu-
dio, crear conciencia sobre el uso razonable de los medicamentos 
supresores del ácido es una necesidad.
INTRODUCTION
Acid suppressive drugs (ASDs) either histamine 2 receptor 
antagonist or, proton pump inhibitors, are some of the most 
commonly used treatment of acid-related diseases and the 
prevention of gastric mucosal damage. 1-2
H2 receptor antagonists (H2RA) are a class of drugs used to 
block the action of histamine on parietal cells in the stom-
ach, decreasing the production of acid by these cells. H2 an-
tagonists are used in the treatment of dyspepsia .1
The exceptional symptom control of histamine 2 receptor 
antagonist or, proton pump inhibitors in acid peptic dis-
orders has led to the indiscriminate use of ASDs for non-
specific, upper gastrointestinal symptoms without proper 
investigation.3 ASDs form the cornerstone in the manage-
ment of upper gastrointestinal bleeding and stress ulcer 
prophylaxis (SUP) in intensive care units (ICU). But many 
patients admitted to general medical wards (non ICU units) 
are also routinely placed on these drugs for SUP when nei-
ther their admission nor the comorbid diagnoses support 
their use for either treatment or prophylaxis. 4
In general, these drugs are considered to be safe. However, 
Proton pump inhibitors have been known to cause short 
term adverse effects like headache, dizziness, diarrhea, fa-
tigue, rashes and abdominal pain which have been report-
ed in 5% of the patients taking proton pump inhibitors.5,6 
Furthermore, chronic therapy of PPIs carries an increased 
risk of bacterial enteritis due to decreased gastric acidity 
allowing colonization of ingested pathogens and also in-
fection with Clostridioides difficile.7,8 Whereas, Long term 
use of PPIs have been associated with increased risk of hip 
fractures, and community acquired pneumonia. 9,10, Such 
risks are worth taking for life saving drugs that are clearly 
indicated, but prescribing PPIs that may not be clinically 
necessary can put patients at risk of complications. Thus, 
the initiation and the continuous use of ASDs without 
correct indications will result in significant costs. In spite 
of the above mentioned concerns with PPIs, they have 
become one of the most commonly prescribed medicines 
worldwide. Some reports suggest that up to 60% of patients 
suffering from dyspepsia are on drugs like PPIs without 
proper indication. 11, 12 A recent study showed that SUP is 
over utilized in the non ICU setting and patients are often 
prescribed ASDs unnecessarily, resulting in significant in-
crease in expenditure. 13 Another hospital-based study re-
vealed that 63% of the patients had no valid indication for 
PPIs 14. A recent study in Saudi Arabia showed that 43% 
of the prescriptions for ASDs were written without an ap-
propriate indication. 15 Similar studies in the past indicated 
that ASDs were misused in hospitals and in general prac-
tice. A study conducted for over one year in a single county 
hospital in the USA showed that 54% were discharged and 
given ASDs without proper indication. 16 Similarly, studies 
published in Europe and Ireland showed that 51% and 57% 
of their patients respectively, were given PPIs improperly.17 
Based on the previous information, we were concerned 
about the extent of prescribing and usage of ASDs in Cen-
tral hospitals in Abha city. Therefore, this study aimed to 
assess the indications of Acid-Suppressive Medications us-
age, to find out percentage of irrational prescriptions with 
Acid-Suppressive Medications (Improper prescriptions 
without justified indication) and to assess the frequency 
of usage of Acid-Suppressive Medications along with their 
dosage.
METHODOLOGY
Study setting
This study was conducted in all wards of Armed Forces 
Hospitals Southern Region (AFHSR) and of Abha Mater-
nity and Children Hospital, both in Abha in Assir region, 
Saudi Arabia. This was a prospective observational study 
to evaluate the prescribing and usage of acid suppressive 
drugs for inpatient and outpatient pharmacies over period 
of 8 weeks, between May and June 2017 by using a form 
that was created for the purpose of this study based on in-
formation gathered from previous studies 15, 18. This study 
included many of acid suppressive drugs medication or-
ders that was prescribed in all hospital wards, and received 
by inpatient and outpatient pharmacies over 8 weeks, re-
gardless of administration of the medications, monitoring 
of medications and patient compliance. The sample size of 
study was (n=185). The case sheets of the patients or the 
outpatient prescription order were reviewed for acid sup-
pressive drugs prescription and relevant data was taken. 
Data analysis was carried out by using of SPSS 16 program. 
Data were expressed as frequency of categorical variables.
RESULTS
Our results showed that 170 (91.9%) of patients who used 
acid suppressive drugs were detected in outpatient phar-
macy and 15 (8.1%) patients in inpatient department of 
Assir hospitals. The age distribution percentages in Assir 
hospital of patients used acid suppressive drugs who were 
included in our study were (48.1%) for patients between 
the age of 18 to 20, (21.6%) for patients between the age of 
21 to 40, (21.1%) for patients between the age of 41 to 60 and 
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(9.2%) of patients were above 60 years old. Those patients 
showed difference acid suppressive drugs prescription per-
centages between male and females, higher proportion of 
female (54.6%) than male patients (45.4%) [Table 1].
Many differences in patient diagnoses that lead to acid sup-
pressive drug prescription were detected in Assir Hospi-
tals. The highest patient percentages that were prescribed 
acid suppressive drug were diagnosed with gastritis and 
diabetes mellitus (DM) with hypertension (HTN) with per-
centages of (20%) for both of them. (8.6 %) of patients were 
diagnosed with HTN, (4.9%) of patients were diagnosed 
with infection, (4.3%) of patients were diagnosed with 
pain, (7.6%) of patients were diagnosis with Gastroesopha-
geal reflux disease (GERD). Finally (34.6%) of patients who 
were prescribed acid suppressive drugs were diagnosed 
with other different. Proton pump inhibitor were the most 
commonly prescribed acid suppressive drugs for the pa-
tients (97.8%) included in the study in comparison to the re-
maining (2.2%) of patient of our study who were prescribed 
histamine 2 antagonist drugs [Table 1].
Table 1. Association between study variables and the Acid suppressive drugs
Study variable Acid suppressive drugs (%)
18-20 89 (48.1%)
21-40 40 (21.6%)
41-60 39 (21.1%)
Above 60 17 (9.2%)
Gender
Male 84 (45.4%)
Female 101 (54.6)
Department
Outpatient 170 (91.9%)
Inpatient 15 (8.1%)
Diagnoses on admission
Gastritis 37 (20%)
Hypertension 16 (8.6%)
DM with HTN 37 (20%)
Infection 9 (4.9%)
Pain 8 (4.3%)
GERD 14 (7.6%)
Others 64 (34.6%)
Type of drug
PPIs 181 (97.8 % )
H2 antacid 4 (2.2%)
Frequency of administration
Once daily 151 (81.6%)
Twice daily 32 (17.3%)
More than twice daily 2 (1.1%)
Rote of administration
Oral 170 (91.9%)
Intravenous 15 (8.1%)
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Majority of patients were prescribed PPIs once daily 151 
(81.6%) in comparison to 32 (17.3%) of patients who were 
prescribed it twice daily. Only 2 (1.1%) of the study patients 
were prescribed PPIs more than twice daily. The route of 
acid suppressive drug administration was orally for 170 
(91.9 %) of patients, while the intravenous route was used 
in only 15 (8.1%) of the study patients. The intravenous 
PPIs used in all patient was omeprazole 40 mg given once 
daily early in morning [Table 1].
The largest percentage of acid suppressive drug prescrib-
ing for the study patients was 169 (91.4%) patients at dis-
charge. The remaining prescribing percentage was during 
hospitalization 16 (8.6%) for study patents. The majority of 
patients included in our study were prescribed acid sup-
pressive drugs as a co-prescribed drug 125 (67.6%), the 
rest of patients were prescribed acid suppressive drugs for 
direct reason to treat different gastrointestinal diseases 60 
(32.4%). The co-prescribed drugs such as non steroidal an-
ti-inflammatory drugs (NSAIDs) (15.7%), aspirin (13.5%), 
antimicrobials (9.2%), steroids (5.4%), antacids (3.8%), oral 
iron (2.7%), alendronate (1.6%), vitamins (1.1%) and other 
(14.6 %). Our results showed that most of the patients who 
were prescribed acid suppressive drugs do not suffer from 
adverse effects (99.5%). Only 0.5% of patient complained 
from Headache [Table 2].
Table 2. Association between the time and reason of prescription Acid suppressive drugs and the study variables
Study variable Acid suppressive drugs (%) Time of drug prescription
At discharge 169 (91.4%)
Hospitalization 16 (8.6%)
Reasons for prescription
Direct 60 (32.4%)
Co-prescribed drug as: 125 (67.6%)
Aspirin 25 (13.5%)
NSAID 29 (15.7%)
Steroids 10 (5.4%)
Alendronate 3 (1.6%)
Antacid 7 (3.8%)
Iron (PO) 5 (2.7%)
Vitamin 2 (1.1%)
Antimicrobial 17 (9.2%)
Others 27 (14.6%)
Adverse effects
Not have 184 (99.5%)
Headache 1 (0.5%)
DISCUSSION
Acid suppressive drugs (ASDs) either histamine 2 receptor 
antagonist or, proton pump inhibitors, are some of the most 
commonly used treatment of acid-related diseases and the 
prevention of gastric mucosal damage. The prescriptions of 
acid suppressive drugs are increasing rapidly in Saudi Ara-
bia as well as worldwide and they have become one of the 
most commonly prescribed drugs 18.
The current study showed that (91.9 %) of patients who 
used acid suppressive drugs were detected in outpatient 
pharmacy and only (8.1 %) were detected in inpatient de-
partment of both Abha hospitals that were included in the 
study. This is in accordance with the previous studies by 
Ramirez E et al 20 and Sandozi T 21 who reported that the use 
of PPIs range from (28.65 %) to (82.65% ) and (45 %) of hos-
pitalized patients, respectively. The lower percentage of in-
patient acid suppressive drug prescription observed in the 
present study might be explained by the easier data gather-
ing from outpatient than from inpatient departments. An-
other explanation is the wakefulness of the clinical pharma-
cists who are working in the inpatient department making 
acid suppression drugs prescription limited at inpatient.
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The majority (51.9%) of patients who were prescribed 
ASDs studied were aged above twenty years old. This was 
in agreement with Nousheen et al 18 study that has all of 
the 100 patients on proton pump inhibitors at the above 
twenty years old age. And in agreement with Mayet AY 
15 study that showed that most patients who use the acid 
suppression drugs located at the ages between 41-59 years 
old. The proportion of elderly patients was higher in our 
study might be because usually they have serious comor-
bid illnesses that bring them to the hospital and require ad-
mission for longer periods. Furthermore, the study patients 
showed difference acid suppressive drugs prescription per-
centages between male and females, the use of PPIs was 
more in females (54.6%) in comparison to males (45.4%). 
This is in accordance with the previous study of Todd H. 
Baron et al 22 but in contradiction with the study of Mayet 
AY 15. This was because most of the hospitals that we col-
lected data from were maternity and pregnancy hospitals 
in which hormonal disorders may be the reason for the in-
crease use of ASDs among females.
The H2 antagonists are mainly indicated therapeutically to 
promote healing of gastric and duodenal ulcers, treat un-
complicated gastro-esophageal reflux disease (GERD) and 
to prevent the occurrence of stress ulcers. [23] H2 antago-
nists are effective in mild to moderate cases of hyperacidity 
and are a cost saving prescription for the patients. If symp-
toms are not being controlled with an H2 antagonist then 
long-term PPIs can be initiated. Proton pump inhibitors are 
the drug of choice for severe acid reflux symptoms, eso-
phagitis and strictures. They are used mostly to promote 
healing of gastric and duodenal ulcers and to treat GERD 
including erosive esophagitis which is either complicated 
or unresponsive to treatment with H2 receptor antagonists. 
They are also the mainstay in the treatment of pathological 
hyper-secretory conditions including Zollinger Ellison syn-
drome. 23 Our study showed that (31.9 %) of the patients 
were prescribed PPIs for gastritis, GERD and as a prophy-
lactic use of NSAID induced gastritis, all of these indica-
tions were according to the criteria of rationality 18,23. On 
the other hand, the other of the prescriptions of PPI (68.1 %) 
were unjustifiable. These results showed no difference in 
ASDs prescribing pattern from the previous studies that in-
dicated that ASDs were misused in hospitals and in general 
practice. A study conducted for over one year in a single 
county hospital in the USA showed that only (22.5%) of all 
outpatient prescriptions of pantoprazole had a proper in-
dication. 16 Another study in 2007 showed that (43%) of the 
prescriptions for ASDs were written without an appropri-
ate indication 15. Similarly, studies published in Europe and 
Ireland showed that 51% and 57% of their patients respec-
tively, were given PPIs improperly. 17. One explanation for 
the ASDs improper use is that practitioners may not know 
the correct indications for ASDs therapy, which may be the 
leading cause of the misuse of acid suppression.
Since the introduction of PPI in the late 1980s, their use 
has increased dramatically worldwide. 24-31 Proton pump 
inhibitor (PPIs) were the most commonly prescribed acid 
suppressive drugs for the patients (97.8%) included in the 
present study in comparison to the remaining (2.2%) of pa-
tient of our study who were prescribed histamine 2 antag-
onist drugs. This is comparable to what had been reported 
by Sandozi et al. where 73 % of clinicians chose a PPI as 
their first-line drug while 27% chose histamine 2 antago-
nist drugs. 21 But this does not conform with the study by 
F. Parente et al 19 who reported that ranitidine, as histamine 
2 antagonist drugs, were the most frequently used drug 
(44.4%), followed by pantoprazole (31.8%) and omeprazole 
(23.0%). However, our results may be closer to the credi-
bility given the cost and effectiveness of PPI compared to 
histamine 2 antagonist drugs. 21
The frequency of administration of PPIs was once daily in 
(81.6%) of cases which was in line with the recommended 
dosage routine of PPIs as once daily but as shown in our 
study it can be given twice daily also for rapid action to 
achieve steady state rapidly as in (17.3%) of our study cas-
es. These results were in accordance with similar studies in 
the past such as the study of Nousheen et al 18 were (97%) 
of the patients prescribed PPIs once daily. Furthermore, the 
oral route of administration of ASDs was the preferable 
route (91.9%) in both of Abha hospitals, the setting of our 
study. The interpretation of this high use of oral route could 
be that the biggest percentage of acid suppressive drug pre-
scribed in this study was for patients at discharge (91.9%). 
In addition, this is likely because the mount of oral ASDs 
dosage is already calculated and did not need effort as in 
injection. Other reasons might be the pain of injection at the 
injection site and the ignorance of the people of the correct 
emplacement injection.
The frequency of prescribing ASDs in our study was found 
to be higher in patients with an existing risk factor and was 
mostly recommended by physicians as concomitant med-
ications (67.6%). The most common concomitant medica-
tions used with PPIs were non steroidal anti inflammatory 
drugs (NSAIDS) (29.2%) in which aspirin composed (13.5%) 
of the NSAIDS prescribed, this is in accordance with the 
studies by Kumar A et al 32 and Raghavendra B et al 33 who 
have found high incidence of co prescription of PPIs with 
NSAIDs. The use of NSAIDs is an important predisposing 
factor for peptic ulcer disease in the community thus one of 
the important indications of PPIs is co-administration with 
NSAIDS to reduce the risk of gastrointestinal bleeding and 
130 Ars Pharm. 2019; 60(2): 125-131
Alakhali KM, Bayoumi HM, Abunakhaa ES, Ahmed M, Alqahtani NS, Jaber RA, et al.
peptic ulcers. The second most prescribed drugs with PPIs 
were antimicrobials, (9.2%), this is a serious issue as (67.6 %) 
of the present study prescriptions of PPI were unjustified 
and it is a well-known fact that patients on proton pump 
inhibitors are also susceptible to colonization of pathogens 
which can lead to bacterial gastroenteritis and also there is 
higher risk of development of infection by Clostridium diffi-
cile (antibiotic associated diarrhoea). 18 The rest of patients 
were prescribed acid suppressive drugs for direct reason 
to treat different gastrointestinal diseases (32.4%). Because 
each drug has side effects, we detected the side effects of 
ASDs among the study patients but most of the patient did 
not suffer from any adverse effects (99.5%). Only (0.5%) of 
patient complained from headache as in the previous study 
of Nousheen et al 18 were headache was seen in only (5 %) of 
the patients. This is justified by the fact that PPIs generally 
are well tolerated 23.
CONCLUSION
Most patients in our study received ASDs improperly (67.6 
%), indicating that Hospitals practice in Southern Region 
of Saudi Arabia, suffers from widespread improper use 
of ASDs. The results of this study highlight the need for a 
monitoring mechanism to periodically study prescription 
patterns of ASDs in order to further reduce its improper 
use. Individual Abha hospitals should develop their own 
strategies to overcome such misuse, notably for PPIs. 
Strategies that can be used include controlled policies like 
formulary restriction, PPI order sheets or stop-orders for 
specific indications. However, a study showed that the ap-
proach was associated with more rational prescribing of 
ASDs and was important in saving resources. Writing and 
implementing guidelines for the uses of ASDs, mainly PPIs, 
by pharmacists can be another strategy to reduce misuse.
REFERENCES
1. Eriksson S, Långström G, Rikner L, Carlsson R and Naesdal 
J. Omeprazole and H2-receptor antagonists in the acute treat-
ment of duodenal ulcer, gastric ulcer and reflux oesophagitis. 
Eur. J. Gastroenterol. Hepatol , 1995, 7 467-475.
2. Blume H, Donath F, Warnke A and Schug B. Pharmacokinetic 
drug interaction profiles of proton pump inhibitors. Drug Saf, 
2006, 29(9) 769-84. Doi:10.2165/00002018-200629090-00002
3. Bashford JN, Norwood J and Chapman SR. Why patients are 
prescribed proton pump inhibitors? Retrospective analysis of 
link between morbidity and prescribing in the General Prac-
tice Research Database. BMJ, 1998, 15 317 (7156) 452-6
4. Julapalli VR and Graham DY. Appropriate use of intra-
venous proton pump inhibitors in the management of 
bleeding peptic ulcer. Dig Dis Sci, 2005, 50 1185-93. Doi: 
10.1177/1756283X09352095
5. Katelaris PH. Proton pump inhibitors. Med. J. Aust. 1998, 169 
(4) 208-11.
6. Reilly JP. Safety profile of the proton-pump inhibitors. Am. J. 
Health-Syst. Pharm., 1999, 56 (23 Suppl 4) 11-7. Doi:10.1093/
ajhp/56.suppl_4.S11
7. Lewis SJ, Franco S, Young G, O and Keefe SJ. Altered bow-
el function and duodenal bacterial overgrowth in patients 
treated with omeprazole. Aliment Pharmcol Ther , 1996, 10 
(4) 557-61.
8. Waldum HL, Brenna E, Kleveland PM, Sandvik AK and 
Syversen U. Review article: the use of gastric acid-inhibitory 
drugs, physiological and pathophysiological considerations. 
Aliment Pharmacol Ther 1993, 7 (6) 589-96.
9. Yang YX, Lewis JD, Epstein S and Metz DC. Long term proton 
pump inhibitor therapy and risk of hip fracture. JAMA, 2006, 
296(24) 2947–53. Doi:10.1001/jama.296.24.2947
10. Eurich DT, Sadowski CA, Simpson SH, Marrie TJ and Ma-
jumdar SR. Recurrent community-acquired pneumonia in pa-
tients starting acid-suppressing drugs. Am J Med, 2010, 123 
(1) 47-53. Doi:10.1016/j.amjmed.2009.05.032
11. Sachs G. Proton pump inhibitors and acid-related diseases. 
Pharmacotherapy 1997, 17 (1) 22-37.
12. Bashford JN, Norwood J and Chapman SR. Why patients are 
prescribed proton pump inhibitors? Retrospective analysis of 
link between morbidity and prescribing in the General Prac-
tice Research Database. BMJ, 1998, 317 (7156) 452-6.
13. Heidelbaugh JJ and Inadomi JM. Magnitude and economic 
impact of inappropriate use of stress ulcer prophylaxis in 
Non-ICU hospitalized patients. Am J Gastroenterol, 2006, 
101:2200-5. Doi:10.1111/j.1572-0241.2006.00839.x
14. Sebastian SS, Kernan N, Qasim A, O’Morain CA and Buckley 
M. Appropriateness of gastric antisecretory therapy in hospi-
tal practice. Indian J Med Sci. 2004, 172:115-7
15. Ahmed Yacoob. Improper Use of Antisecretory drugs in a 
Tertiary Care Teaching Hospital: An Observational Study. 
Saudi J Gastroenterol , 2007, 13(3):124-128. Doi: 10.4103/1319-
3767.33463
16. Brandhagen DJ, Phaley AM, Onstad GR, Freeman ML and 
Lurie N. Omeprazole use at an urban county teaching hospi-
tal. J. Gen Intern Med, 1995, 109:513-5.
17. Maclaren R, Obritsch MD, Sherman DS, Jung R and Fish DN. 
Assessing adherence to an intravenous pantoprazole guide-
line. J Pharm Technol, 2006, 22:15-21.
18. Nousheen, Tadvi NA and Shareef SM. Use of proton pump 
inhibitors in general practice: Is it rationale? IJMRHS, 2014, 
3(1) 37-42
19. Parente F, Cucino C, Gallus S, Bargiggia S, Greco S, Pastore L 
and Bianchi Porro G. Hospital use of acid-suppressive med-
ications and its fall out on prescribing in general practice: a 
131Ars Pharm. 2019; 60(2): 125-131
Evaluation of Acid-Suppressive Medications Prescribing and Usage in Central Hospitals in Abha Region, Saudi Arabia
1-month survey. Aliment Pharmacol Ther, 2003, 17 (12) 1503-
6.
20. Ramirez E, Lei S, Borobia A, Pinana E, Fudio S, Munoz R and 
et al. Overuse of PPIs in patients at admission, during treat-
ment, and at discharge in a tertiary Spanish hospital, Curr 
Clin Pharmacol , 2010, 5(4):288-97.
21. Tasneem Sandozi. A Comparative Study of Cost Analysis of 
H2 Antagonists and Proton Pump Inhibitors in a Tertiary 
Care Hospital. RJPBCS, 2013, 4(5): 888-897
22. Baron TH, Ramirez B and Richter JE. Gastrointestinal mo-
tility disorders during pregnancy. Ann Intern Med, 1993, 
;118(5):366-75
23. Hoogerwerf WA, Pasricha PJ. Pharmacotherapy of Gastric 
acidity, peptic ulcers, and gastroesophageal Reflux disease. 
In: Laurence L. Brunton, John S Lazo Keith L.Parker, eds. The 
Pharmacological basis of therapeutics; Goodman & Gilman, 
2006, 11ed. 971-72.
24. Ahrens D, Chenot J-F, Behrens G, Grimmsmann T and Kochen 
MM. Appropriateness of treatment recommendations for PPI in 
hospital discharge letters. Eur J Clin Pharmacol, 2010; 66(12):1265-
71. Doi:10.1007/s00228-010-0871-9
25. Walker NM and McDonald J. An evaluation of the use of pro-
ton pump inhibitors. Pharm World Sci, 2001; 23(3):116-7.
26. Eid SM, Boueiz A, Paranji S, Mativo C, Landis RBA and 
Abougergi MS. Patterns and Predictors of Proton Pump In-
hibitor Overuse among Academic and Non-Academic Hospi-
talists. Intern Med, 2010; 49 (23):2561-8.
27. Scagliarini R, Magnani E, Praticò A, Bocchini R, Sambo P and 
Pazzi P. Inadequate Use of Acid-Suppressive Therapy in Hospital-
ized Patients and Its Implications for General Practice. Dig Dis Sci, 
2005; 50(12):2307-11. Doi:10.1007/s10620-005-3052-4
28. Molloy D, Molloy A, O’Loughlin C, Falconer M and Hennessy M. 
Inappropriate use of proton pump inhibitors. Ir J Med Sci, 2010; 
179(1):73-5. Doi:10.1007/s11845-009-0426-1
29. Mat Saad AZ, Collins N, Lobo MM, O’Connor HJ. Proton 
pump inhibitors: a survey of prescribing in an Irish gener-
al hospital. Int J Clin Pract. 2005;59:31-4. Doi:10.1111/j.1742-
1241.2004.00298.x
30. Law JK, Andrews CN and Enns R. Intravenous proton pump 
inhibition utilization and prescribing patterns escalation: a 
comparison between early and current trends in use. Gastro-
intest Endosc, 2009 ; 69:3-9.
31. Batuwitage BT, Kingham JGC, Morgan NE and Bartlett RL. 
Inappropriate prescribing of proton pump inhibitors in pri-
mary care. Postgrad Med J 2007; 83(975):66-8. Doi:10.1136/
pgmj.2006.051151
32. Kumar A, Dalai CK, Ghosh AK and Ray M. Drug utilization 
study of co-administration of nonsteroidal anti-inflammatory 
drugs and gastroprotective agents in an orthopaedics outpa-
tients department of a tertiary care hospital in West Bengal. 
IJBCP, 2013; 2(2):199-202.
33. Raghavendra B, Narendranath S, Ullal SD, Kamath R, Pai 
MR, Kamath S and et al. Trends in prescribing gastroprotec-
tive agents with non steroidal anti-inflammatory drugs in an 
Orthopaedic outpatient unit of a tertiary care hospital. J Clin 
Diagn Res, 2009; 3(3):1553-6.
